Grant: Master's Award: Canada Graduate Scholarships
McMaster University
$17,500.00
Determining the mechanism of the ImuABC translesion DNA synthesis complex
FY 2022-23
Summary
Translesion DNA synthesis (TLS) is a mechanism that allows DNA damage bypass during DNA replication. The ImuABC complex of TLS is present in one third of bacteria. It is comprised of the protein ImuA that contains a RecA domain, the inactive polymerase ImuB, and the low-fidelity polymerase ImuC. The lack of proofreading activity in ImuC can produce mutations that favour the survival of bacteria and lead to antimicrobial resistance (AMR). TLS has been shown to contribute to AMR in high-priority antibiotic-resistant pathogens, including Pseudomonas aeruginosa and Mycobacterium tuberculosis. Thus, it has become urgent to better understand DNA damage bypass mechanisms to curb AMR. The mechanism of the ImuABC complex is poorly understood due to the insolubility of the proteins when purified in vitro. This project aims to characterize ImuA and ImuBN?34 of Myxococcus xanthus, through structural and biochemical analysis, to solve critical functional domains that could serve as potential drug targets. First, this project aims to determine the function of ImuBN?34 by identifying DNA-binding residues and the ImuA-ImuBN?34 binding interface. DNA binding will be quantified by fluorescence polarization, and protein-protein interactions will be measured by microscale thermophoresis. Second, this project will determine the function of ImuA by solving the protein structure by X-ray crystallography. ImuA will be strategically truncated to overcome its insolubility, then crystallized with DNA to solve the protein-ligand structure. Other potential RecA-like functions of ImuA will be investigated, including ATPase activity. Together, understanding the structure and function of ImuA/B will reveal critical active sites to specifically target the mutagenic TLS pathway with antimicrobial drugs.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
486022
Name
Lichimo Kristi L
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Determining the mechanism of the ImuABC translesion DNA synthesis complex
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Antimicrobial Resistance; Crystallography; Dna Damage Bypass; Molecular Mechanisms In Vitro; Myxococcus Xanthus; Pathogenic Bacteria; Protein Insolubility; Protein Structure; Protein-Dna Interactions; Protein-Protein Interactions
Abstract
Translesion DNA synthesis (TLS) is a mechanism that allows DNA damage bypass during DNA replication. The ImuABC complex of TLS is present in one third of bacteria. It is comprised of the protein ImuA that contains a RecA domain, the inactive polymerase ImuB, and the low-fidelity polymerase ImuC. The lack of proofreading activity in ImuC can produce mutations that favour the survival of bacteria and lead to antimicrobial resistance (AMR). TLS has been shown to contribute to AMR in high-priority antibiotic-resistant pathogens, including Pseudomonas aeruginosa and Mycobacterium tuberculosis. Thus, it has become urgent to better understand DNA damage bypass mechanisms to curb AMR. The mechanism of the ImuABC complex is poorly understood due to the insolubility of the proteins when purified in vitro. This project aims to characterize ImuA and ImuBN?34 of Myxococcus xanthus, through structural and biochemical analysis, to solve critical functional domains that could serve as potential drug targets. First, this project aims to determine the function of ImuBN?34 by identifying DNA-binding residues and the ImuA-ImuBN?34 binding interface. DNA binding will be quantified by fluorescence polarization, and protein-protein interactions will be measured by microscale thermophoresis. Second, this project will determine the function of ImuA by solving the protein structure by X-ray crystallography. ImuA will be strategically truncated to overcome its insolubility, then crystallized with DNA to solve the protein-ligand structure. Other potential RecA-like functions of ImuA will be investigated, including ATPase activity. Together, understanding the structure and function of ImuA/B will reveal critical active sites to specifically target the mutagenic TLS pathway with antimicrobial drugs.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Lichimo, Kristi L
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~